LiteOdyssey AI achieves state-of-the-art rare-disease diagnosis

Researchers have developed LiteOdyssey, a lightweight AI agent designed for interpretable rare-disease diagnosis. This framework guides a reasoning language model through a clinical genetics workflow, utilizing human-AI collaboration and publicly available biomedical tools. LiteOdyssey achieved state-of-the-art performance on two challenging benchmarks, demonstrating high disease recall without requiring extensive fine-tuning, multi-agent ensembles, or large retrieval databases. AI

IMPACT Demonstrates a novel approach to rare-disease diagnosis using lightweight AI agents, potentially improving accessibility and transparency in medical AI.

RANK_REASON The cluster contains a research paper detailing a new AI agent for rare-disease diagnosis. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.AI →

• alphaXiv
• CatalyzeX
• DagsHub
• Gotit.pub
• GPT-5.4
• Hugging Face
• LIRICAL
• LiteOdyssey
• Orphanet
• PhenoPacket Store
• Policy Iteration with Human Feedback
• ScienceCast

• paper
• model release
• product

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →